Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
Novo Nordisk petitions the FDA to exclude liraglutide from the 503B Bulks List, citing safety risks, lack of clinical need, ...
President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and ...
Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%. Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial ...
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback